Clinics in Chest Medicine

Article	Citations
Indoor Air Pollution and Respiratory Health	91
Silicosis: An Update and Guide for Clinicians	61
Allergic Bronchopulmonary Aspergillosis	56
Diagnosis of Primary Ciliary Dyskinesia	40
Pneumothorax	37
Working in Smoke:	35
Sex Differences in Pulmonary Hypertension	29
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease	29
The Respiratory Risks of Ambient/Outdoor Air Pollution	29
Coal Workers’ Pneumoconiosis and Other Mining-Related Lung Disease	28
Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension	26
Pleural Tuberculosis	24
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation	20
Sex Differences in Obstructive Sleep Apnea	19
Gender Differences in Critical Illness and Critical Care Research	18
Pleural Fluid Analysis	17
Pulmonary Hypertension in Left Heart Disease	17
Congenital Heart Disease-Associated Pulmonary Hypertension	16
The Changing Nature of Wildfires	16
Nontuberculous Mycobacteria	16
Adaptation and Maladaptation of the Right Ventricle in Pulmonary Vascular Diseases	16
Patient-Centered and Family-Centered Care in the Intensive Care Unit	16
Respiratory Health Effects of Exposure to Cleaning Products	15
Screening for Occupational Lung Cancer	15
Microbiology and the Microbiome in Bronchiectasis	15

Nontuberculous Mycobacterial Infections in Cystic Fibrosis	15
Parapneumonic Effusion and Empyema	15
Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome	14
Chylothorax and Pseudochylothorax	14
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections	13
Bronchiectasis in Childhood	13
Sleep Deficiency	13
Update on Clinical Outcomes of Highly Effective Modulator Therapy	13
Medical Thoracoscopy	13
Occupational Contributions to Interstitial Lung Disease	12
The Need for Social and Environmental Determinants of Health Research to Understand and Intervene on Racial/Ethnic Disparities in Obstructive Sleep Apnea	12
Diagnosis and Evaluation of Bronchiectasis	12
Update on Innate and Adaptive Immunity in Cystic Fibrosis	11
Coronavirus Disease-2019 in the Immunocompromised Host	11
Health Disparities in Environmental and Occupational Lung Disease	11
Management of Connective Tissue Disease-Associated Interstitial Lung Disease	10
Interstitial Lung Disease in 2020	10
Sleep Deficiency and Cardiometabolic Disease	10
Women and Lung Cancer	10
Differences Between Men and Women with Chronic Obstructive Pulmonary Disease	10
Future Directions in Bronchiectasis Research	10
Preoperative Assessment and Perioperative Management of the Patient with Pulmonary Vascular Disease	9
Supporting Professionals in Critical Care Medicine	9
Pulmonary Hypertension in Pregnancy	9
Occupational Bronchiolitis	9
Sleep Deficiency, Sleep Apnea, and Chronic Lung Disease	9
The Role of Exercise Testing in Pulmonary Vascular Disease	9
Challenges Faced by Women with Cystic Fibrosis	9
SARS-CoV-2 Infection and COVID-19 in Children	9
Radiology of Bronchiectasis	9
Sleep Deficiency and Opioid Use Disorder	9
Lessons Learned from Health Disparities in Coronavirus Disease-2019 in the United States	9
Interstitial Lung Diseases and the Impact of Gender	8
Management of Idiopathic Pulmonary Fibrosis	8
Integrative Omics to Characterize and Classify Pulmonary Vascular Disease	8
Management of Pneumothorax	8
The Impact of Social Determinants of Health on Gender Disparities Within Respiratory Medicine	8
Sleep Deficiency in Young Children	8
Malignant Pleural Effusions	8
Update on Climate Change	8
Clinical Relevance and Management of “Pre–Interstitial Lung Disease”	8
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era	8
Pulmonary Considerations for Pregnant Women	7
Survivorship After Critical Illness and Post-Intensive Care Syndrome	7
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice	7
Management of Mental Health in Cystic Fibrosis	7
Obstetric Disorders and Critical Illness	7
Diagnosis and Management of Fibrotic Interstitial Lung Diseases	7
Climate Change, Air Quality, and Pulmonary Health Disparities	7
Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis	7

Indwelling Pleural Catheters	7
Lung Transplant Procedure of Choice	7
Work Around the Clock	7
Genetics of Cystic Fibrosis	7
Joining Forces	6
Sleep Deficiency in the Elderly	6
COVID-19 and the Transformation of Intensive Care Unit Telemedicine	6
Asthma and Chronic Obstructive Pulmonary Disease	6
Advances in Ventilator Management for Patients with Acute Respiratory Distress Syndrome	6
Family Planning and Reproductive Health in Cystic Fibrosis	6
Chest Imaging in the Diagnosis of Occupational Lung Diseases	6
Pulmonary Arterial Hypertension Secondary to Drugs and Toxins	6
Bronchiectasis from 2012 to 2022	6
Sex Differences and the Role of Sex Hormones in Pulmonary Hypertension	6
COVID-19 in Patients with Chronic Lung Disease	6
Group 3 Pulmonary Hypertension	6
Disparities in Sleep-Disordered Breathing: Upstream Risk Factors, Mechanisms, and Implications	6
Impact of Sex on Sleep Disorders Across the Lifespan	5
Antibiotic Management in Bronchiectasis	5
The Spectrum of Airway Involvement in Inflammatory Bowel Disease	5
Informatics Approaches for Recognition, Management, and Prevention of Occupational Respiratory Disease	5
Malignant Pleural Mesothelioma	5
Occupational Respiratory Infections	5
Interstitial Lung Disease and Sarcoidosis	5
Care Delivery Models and Interstitial Lung Disease	5
The Pathogenesis of Bronchiectasis	5
Culture, Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria	5
Indoor Microbial Exposures and Chronic Lung Disease	5
Management of Fibrotic Hypersensitivity Pneumonitis	5
History of Lung Transplantation	5
Pulmonary Vascular Disease as a Systemic and Multisystem Disease	5
Treatment Approaches to Mycobacterium abscessus Pulmonary Disease	5
Sleep Deficiency in Obstructive Sleep Apnea	5
The Evolution in Nomenclature, Diagnosis, and Classification of Pulmonary Hypertension	5
Health Equity and Respiratory Diseases in Low- and Middle-Income Countries	5
Critical Care Management of the Patient with Pulmonary Hypertension	4
The Use of Extracorporeal Membrane Oxygenation for COVID-19	4
Application of Focused Assessment with Sonography for Trauma in the Intensive Care Unit	4
Setting up a Pleural Disease Service	4
Anatomy and Applied Physiology of the Pleural Space	4
Lung Transplantation in Coronavirus-19 Patients	4
Hepatic Hydrothorax and Congestive Heart Failure Induced Pleural Effusion	4
Endocrine Complications of Cystic Fibrosis	4
Critical Care Management of the Lung Transplant Recipient	4
Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease	4
Pathophysiology of Hypoxemia in COVID-19 Lung Disease	4
Management of the Critically Ill Patient with Pulmonary Arterial Hypertension and Right Heart Failure	4
Molecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease	4
Expanding the Lung Donor Pool	4
Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis	4
Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis	3
Point-of-Care Ultrasound in the Intensive Care Unit	3
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis	3
Contemporary Pharmacotherapeutic Approach in Pulmonary Arterial Hypertension	3
Effects of Sleep Deficiency on Risk, Course, and Treatment of Psychopathology	3
Sleep Deficiency in Pregnancy	3
Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial	3
Non-Modulator Therapies	3
The Past, Present, and Near Future of Lung Allocation in the United States	3
Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems	3
Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease	3
Future of Lung Transplantation	3
Tobacco Use and Tobacco Dependence Management	3
Disparities Across the Continuum of Lung Cancer Care	3
Race, Racism, and Respiratory Health	3
Ultrasound-Guided Pleural Investigations	3
Listing Dilemmas	3
Providing Patient-Centered Care in Interstitial Lung Disease	3
Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations	3
Personalized Medicine for Pulmonary Hypertension:	3
Stress and Loss of Ovarian Function	3
Post-COVID Interstitial Lung Disease and Other Lung Sequelae	3
Environmental Sources and Transmission of Nontuberculous Mycobacteria	3
Pharmacology Considerations in Women in Lung Disease and Critical Care	2
Cardiac Sarcoidosis	2
Antibody-Mediated Rejection	2
Rethinking Idiopathic Pulmonary Fibrosis	2
Pulmonary Vascular Diseases Associated with Infectious Disease—Schistosomiasis and Human Immunodeficiency Viruses	2
Cutaneous Sarcoidosis	2
Adding Insult to Injury	2

Sleep Deficiency	2
Lung Diseases Unique to Women	2
Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient	2
Caring for the Critically Ill Patient with COVID-19	2
Advances in Sepsis Care	2
Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?	2
Biomarkers in Sarcoidosis	2
Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease	2
Emerging Approaches to Monitor and Modify Care in the era of CFTR Modulators	2
Investigation and Management of Bronchiectasis in Nontuberculous Mycobacterial Pulmonary Disease	2
Looking Ahead	2
Updates in Pleural Imaging	2
Capnography for Monitoring of the Critically Ill Patient	2
Airway Clearance and Mucoactive Therapies in Bronchiectasis	2
Predictors of Mortality in Sarcoidosis	2
Electronic Cigarettes	2
Health Care Disparities in Pulmonary Arterial Hypertension	2
Acute Rejection and Chronic Lung Allograft Dysfunction	2
Transitions of Care in Cystic Fibrosis	2
Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease	2
Extracorporeal Life Support in Respiratory Failure	2
Structural and Social Determinants of Inequitable Environmental Exposures in the United States	1
Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease	1
Master Clinician and Public Health Practitioner	1
Update on Lung Transplantation for Cystic Fibrosis	1
Sleep Deficiency in Adolescents	1
Drug-induced Lung Disease in the Oncology Patient	1
Lessons Learned from a Global Perspective of Coronavirus Disease-2019	1
Common Noninfectious Complications Following Lung Transplantation	1
Coronavirus Disease-2019 Pneumonia	1
Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia	1
Hematologic and Oncologic Aspects of Sarcoidosis	1
Supporting the Respiratory Health of Migrants and Refugees	1
Radiation Therapy for Lung Cancer	1
Occupational Contributions to Respiratory Health Disparities	1
The Lung Transplant Candidate, Indications, Timing, and Selection Criteria	1
Sarcoidosis-Associated Pulmonary Hypertension	1
Respiratory Infections	1
Role of Bronchoscopy in Diagnosis of Sarcoidosis	1
Fibrotic Pulmonary Sarcoidosis	1
Surgical Resection in Nontuberculous Mycobacterial Pulmonary Disease	1
Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host	1
Pleural Disease	1
Critical Care of the Lung Transplant Patient	1
Host Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease	1
Current Practices in Pediatric Asthma Care	1
Pharmacologic Management of Delirium in the Intensive Care Unit	1
Lessons Learned in Mechanical Ventilation/Oxygen Support in Coronavirus Disease 2019	1
Sleep Deficiency and Health	1
Cystic Fibrosis in the Era of Highly Effective CFTR Modulators	1
Unique Aspects of Asthma in Women	1
Subsolid Nodules	1
Organ Donation, the Non-Perfect Lung Donor, and Variability in Conversion to Transplant	1
Conventional and Novel Approaches to Immunosuppression in Lung Transplantation	1
Bronchiectasis: Advances in Diagnosis and Management	1
Work-Related Upper-Airway Disorders	1
Lung Needle Biopsy and Lung Ablation	1
Pulmonary Hypertension	1
An Overview of Sex and Gender in Pulmonary and Critical Care Medicine	1